RUGGERI, M.; BASILE, M.; ARMUZZI, A.; CICCHETTI, A. Activity-based costing and budget analysis of vedolizumab versus conventional treatments in ulcerative colitis and Crohn’s disease: Analisi Organizzativa e di Budget Dell’introduzione di Vedolizumab Vs Terapie Tradizionali in Colite Ulcerosa e Morbo di Crohn. Global and Regional Health Technology Assessment, [S. l.], v. 4, n. 1, p. 88–99, 2017. DOI: 10.33393/grhta.2017.382. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/382. Acesso em: 21 nov. 2024.